Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Products & comparisons
Product source

Creatine Monohydrate (Ryse) in the NIH Dietary Supplement Label Database

This NIH DSLD record lists a Ryse powder labelled Creatine Monohydrate at 5 grams per labelled serving. It is a label declaration only, not evidence of efficacy, safety or approval. [1]

Automatic summary · not editorially reviewed

Label · NIH DSLD
Creatine MonohydrateOriginal label · NIH DSLD
Creatine Monohydrate

FROM THE ORIGINAL LABEL

A closer look at the product

Pack contents
300 Gram(s) · 10.6 Ounce(s)
Label serving
5 Gram(s)
Servings per container
60
Barcode / SKU
8 54050 00848 2
Open original label (PDF)
Ingredients & declared amounts1

Amounts from the label, per specified serving. These are manufacturer declarations, not a personal dosage recommendation.

IngredientAmountPer label serving
Creatine Monohydrate5 Gram(s)5 Gram(s)

Source: National Institutes of Health, Office of Dietary Supplements · Dietary Supplement Label Database. Label snapshot; packaging and formulation may have changed.

The key findings

  1. The record is DSLD entry 338468, labelled Creatine Monohydrate from the brand Ryse. [1]

  2. The label declares a powder with 5 grams of Creatine Monohydrate per labelled serving. [1]

  3. DSLD inclusion does not establish efficacy, safety, FDA approval, laboratory verification or retail availability. [1]

The source at a glance

Brand
Ryse
Form
Powder
Pack contents
300 Gram(s) · 10.6 Ounce(s)
Label serving
5 Gram(s)
Ingredients listed
Creatine Monohydrate
Record type / format
Product label/database record (NIH DSLD); not a study or independent test.
Scope / context
The described product: a Ryse powder labelled Creatine Monohydrate, DSLD record 338468. Not a patient population.
Summary based on
Product label / database record

NIH DSLD record 338468 for a Ryse creatine powder

The source is a record in the NIH Office of Dietary Supplements Dietary Supplement Label Database (DSLD), entry 338468. The label name is Creatine Monohydrate and the declared brand is Ryse. The label entered the database on 25 September 2025; the source notes this is not a product launch date. The record sits in the DSLD category Non-Nutrient/Non-Botanical. It describes label declarations only and supplies no independent testing, price or batch certificate.

Supporting source [1]

Declared form and listed amount per labelled serving

The label lists the physical form as powder. The only declared ingredient in the record is Creatine Monohydrate, at 5 grams per labelled serving. This amount is a label fact, not personal dosing advice, and the record gives no serving schedule or use instructions.

Supporting source [1]

What a DSLD listing does not establish about this product

Inclusion in DSLD does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. The record therefore says nothing about whether the product works or is superior to others, and it is not an endorsement. It also does not confirm that the declared 5 grams per serving was measured in the finished product.

Supporting source [1]

How to interpret this

Product label record; not evidence of efficacy or approval. Abstract-level scope does not apply; this is a database entry describing label declarations only, with no independent testing, price or batch certificate.

Based on a product label or database record. This does not establish effectiveness, independent batch testing, approval or current availability.

Source & supporting passages

[1]
Creatine Monohydrate

Ryse · dsld.od.nih.gov

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    Record 338468. Product label name: Creatine Monohydrate
  2. Finding 2 ↑

    Creatine Monohydrate: 5 Gram(s) per labelled serving
  3. Finding 3 ↑

    DSLD inclusion does not establish efficacy, safety,

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…